Skip to main content
. 2022 Nov 3;14(11):2370. doi: 10.3390/pharmaceutics14112370

Figure 3.

Figure 3

Remodeling of probiotic-derived bEVs against BBB related anomalies. The figure was created using BioRender.com (https://app.biorender.com; accessed on 2 November 2022).